Campbell Bradley L 4
4 · AMICUS THERAPEUTICS, INC. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Campbell Bradley L
DirectorPresident and CEO
Transactions
- Sale
Common Stock
[F1]2026-03-02$14.35/sh−22,500$322,839→ 998,680 total
Footnotes (1)
- [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.34 to $14.37 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Christian Formica, Attorney-in-Fact|2026-03-04